EFFICACY OF SGLT-2 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES: SINGLE CENTRE EXPERIENCE
Objective: Sodium-glucose transporter-2 (SGLT-2) inhibitors lower blood glucose levels by reducing renal glucose reabsorption without affecting insulin secretion. The aim of our study was to evaluate the effect of SGLT-2 inhibitor treatment on glycemic control and the possible superiority of the dru...
Saved in:
| Main Authors: | Ramazan Çakmak, Golpouneh Alizad Oghyanous, Özlem Soyluk Selçukbiricik, Kubilay Karşıdağ |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul University Press
2025-01-01
|
| Series: | İstanbul Tıp Fakültesi Dergisi |
| Subjects: | |
| Online Access: | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/A4D4179A8B4040629597C48450358B95 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New opportunities for the correction of type 2 diabetes mellitus in patients with liver diseases
by: L. Yu. Morgunov, et al.
Published: (2022-01-01) -
SGLT2 inhibitor administration to two patients with diabetes mellitus with ascites due to cirrhosis
by: Koji Nagayama, et al.
Published: (2025-07-01) -
The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis
by: Chung-Shu Lee, et al.
Published: (2025-05-01) -
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease
by: Tarunveer S. Ahluwalia, et al.
Published: (2024-02-01) -
Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy
by: Kong Ling-li, et al.
Published: (2021-01-01)